Literature DB >> 30070712

Vascular Immunotargeting: Take the Highway to the First Exit.

Vladimir R Muzykantov1, Jacob S Brenner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30070712      PMCID： PMC6583779          DOI： 10.1002/hep.30141

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

Review 1.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

2.  Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia

Authors:  Müfide Okay; Sıla Çetik; İbrahim C. Haznedaroğlu
Journal:  Turk J Haematol       Date:  2019-05-09       Impact factor: 1.831

Review 3.  Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines.

Authors:  Yufu Tang; Zhongzheng Yu; Xiaomei Lu; Quli Fan; Wei Huang
Journal:  Adv Sci (Weinh)       Date:  2022-03-04       Impact factor: 17.521
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.